Recalls, Market Withdrawals, & Safety Alerts > Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Recalls, Market Withdrawals, & Safety Alerts > Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

An update to a previous MedWatch Safety Alert: Infants’ Ibuprofen Concentrated Oral Suspension by Tris Pharma: Recall - Due to Potential Higher Concentrations of Ibuprofen wasjust updated on the FDA Recalls webpage. Three additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, have been added.

 

You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm627780.htm